Breast Cancer Research - oalib

OALib Journal期刊
ISSN: 2333-9721
费用：99美元

投递稿件

为什么选择我们？ >>

- 开源期刊

- 同行审议

- 快速出刊

- 终身存储

- 免费检索

- 免费推广

- 更多...

- 搜索引擎

Breast Cancer Research

ISSN Print: 1465-5411

ISSN Online:

主页: http://breast-cancer-research.com

分享:

Mammographic density and breast cancer risk: the role of the fat surrounding the fibroglandular tissue

Mari？tte Lokate, Petra HM Peeters, Linda M Peelen, Gerco Haars, Wouter B Veldhuis, Carla H van Gils

erbB3 recruitment of insulin receptor substrate 1 modulates insulin-like growth factor receptor signalling in oestrogen receptor-positive breast cancer cell lines

Janice M Knowlden, Julia MW Gee, Denise Barrow, John F Robertson, Ian O Ellis, Robert I Nicholson, Iain R Hutcheson

Targeting bone metastases starting from the preneoplastic niche: home sweet home

Daniele Santini, Bruno Vincenzi, Francesco Pantano, Giuseppe Tonini, Francesco Bertoldo

Quantitative copy number analysis by Multiplex Ligation-dependent Probe Amplification (MLPA) of BRCA1-associated breast cancer regions identifies BRCAness

Esther H Lips, Nadja Laddach, Suvi P Savola, Marieke A Vollebergh, Anne MM Oonk, Alex LT Imholz, Lodewyk FA Wessels, Jelle Wesseling, Petra M Nederlof, Sjoerd Rodenhuis

Evaluation of prognostic and predictive value of microtubule associated protein tau in two independent cohorts

Maria T Baquero, Karen Lostritto, Mark D Gustavson, Kimberly A Bassi, Franck Appia, Robert L Camp, Annette M Molinaro, Lyndsay N Harris, David L Rimm

Regulation of breast cancer metastasis by Runx2 and estrogen signaling: the role of SNAI2

Nyam-Osor Chimge, Sanjeev K Baniwal, Gillian H Little, Yi-bu Chen, Michael Kahn, Debu Tripathy, Zea Borok, Baruch Frenkel

Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study

Harri Sihto, Johan Lundin, Mikael Lundin, Tiina Lehtim？ki, Ari Ristim？ki, Kaija Holli, Liisa Sailas, Vesa Kataja, Taina Turpeenniemi-Hujanen, Jorma Isola, P？ivi Heikkil？, Heikki Joensuu

Replacement of E-cadherin by N-cadherin in the mammary gland leads to fibrocystic changes and tumor formation

Ahmed M Kotb, Andreas Hierholzer, Rolf Kemler

The devil is in the methods: lineage tracing, functional screens and sequencing, hormones, tumour-stroma interactions, and expansion of human breast tumours as xenografts

María dM Vivanco, John Stingl, Robert B Clarke, Mohamed Bentires-Alj

Male breast carcinoma: increased awareness needed

Jonathan White, Olive Kearins, David Dodwell, Kieran Horgan, Andrew M Hanby, Valerie Speirs

Minimal residual disease and circulating tumor cells in breast cancer

Michail Ignatiadis, Monica Reinholz

Landscape of somatic allelic imbalances and copy number alterations in HER2-amplified breast cancer

Johan Staaf, G？ran J？nsson, Markus Ringnér, Bo Baldetorp, ？ke Borg

A protective role for BRCA2 at stalled replication forks

Gurushankar Chandramouly, Nicholas A Willis, Ralph Scully

The chemokine receptor CX3CR1 is directly involved in the arrest of breast cancer cells to the skeleton

Whitney L Jamieson-Gladney, Yun Zhang, Alan M Fong, Olimpia Meucci, Alessandro Fatatis

Breast tumors from CHEK2 1100delC-mutation carriers: genomic landscape and clinical implications

Taru A Muranen, Dario Greco, Rainer Fagerholm, Outi Kilpivaara, Kati K？mpj？rvi, Kristiina Aittom？ki, Carl Blomqvist, P？ivi Heikkil？, ？ke Borg, Heli Nevanlinna

Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL

Luke Piggott, Nader Omidvar, Salvador Pérez, Matthias Eberl, Richard WE Clarkson

A new gene expression signature, the ClinicoMolecular Triad Classification, may improve prediction and prognostication of breast cancer at the time of diagnosis

Dong-Yu Wang, Susan J Done, David R McCready, Scott Boerner, Supriya Kulkarni, Wey Leong

Fulvestrant-induced expression of ErbB3 and ErbB4 receptors sensitizes oestrogen receptor-positive breast cancer cells to heregulin β1

Iain R Hutcheson, Lindy Goddard, Denise Barrow, Richard A McClelland, Hayley E Francies, Janice M Knowlden, Robert I Nicholson, Julia MW Gee

Impact of oncogenic K-RAS on YB-1 phosphorylation induced by ionizing radiation

Mahmoud Toulany, Tim-Andre Schickflu？, Wolfgang Eicheler, Rainer Kehlbach, Birgit Schittek, H Peter Rodemann

Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice

Laura N Burga, Hai Hu, Ashish Juvekar, Nadine M Tung, Susan L Troyan, Erin W Hofstatter, Gerburg M Wulf

Breast cancer cell migration is regulated through junctional adhesion molecule-A-mediated activation of Rap1 GTPase

Elaine A McSherry, Kieran Brennan, Lance Hudson, Arnold DK Hill, Ann M Hopkins

Enhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancers

Huiling Xu, Max Yan, Jennifer Patra, Rachael Natrajan, Yuqian Yan, Sigrid Swagemakers, Jonathan M Tomaszewski, Sandra Verschoor, Ewan KA Millar, Peter van der Spek, Jorge S Reis-Filho, Robert G Ramsay, Sandra A O'Toole, Catriona M McNeil, Robert L Sutherland, Michael J McKay, Stephen B Fox

A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation

Angelika Brekman, Kathryn E Singh, Alla Polotskaia, Nandini Kundu, Jill Bargonetti

Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression

Caitlin D May, Nathalie Sphyris, Kurt W Evans, Steven J Werden, Wenjun Guo, Sendurai A Mani

Gene signatures of breast cancer progression and metastasis

David I Rodenhiser, Joseph D Andrews, Theodore A Vandenberg, Ann F Chambers

Quantification and clinical relevance of gene amplification at chromosome 17q12-q21 in human epidermal growth factor receptor 2-amplified breast cancers

Pierre-Jean Lamy, Frédéric Fina, Caroline Bascoul-Mollevi, Anne-Claire Laberenne, Pierre-Marie Martin, L'Houcine Ouafik, William Jacot

Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basal-like breast cancers

Max Yan, Nicholas Jene, David Byrne, Ewan KA Millar, Sandra A O'Toole, Catriona M McNeil, Gaynor J Bates, Adrian L Harris, Alison H Banham, Robert L Sutherland, Stephen B Fox

Quantitative assays for the measurement of HER1-HER2 heterodimerization and phosphorylation in cell lines and breast tumors: applications for diagnostics and targeted drug mechanism of action

Lisa DeFazio-Eli, Kristi Strommen, Trang Dao-Pick, Gordon Parry, Laurie Goodman, John Winslow

Estrogen receptor β represses Akt signaling in breast cancer cells via downregulation of HER2/HER3 and upregulation of PTEN: implications for tamoxifen sensitivity

Karolina Lindberg, Luisa A Helguero, Yoko Omoto, Jan-？ke Gustafsson, Lars-Arne Haldosén

High hopes for RANKL: will the mouse model live up to its promise?

Tamara Tanos, Cathrin Brisken

3D culture reveals a signaling network

Senthil K Muthuswamy

Appraisal of progenitor markers in the context of molecular classification of breast cancers

Izhak Haviv

Chasing the immortal strand: evidence for nature's way of protecting the breast genome

Nikolajs Zeps, Christine Hemmings

Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3

Yasuo Kodera, Yasufumi Katanasaka, Yuka Kitamura, Hitoshi Tsuda, Kazuto Nishio, Tomohide Tamura, Fumiaki Koizumi

Impact of established prognostic factors and molecular subtype in very young breast cancer patients: pooled analysis of four EORTC randomized controlled trials

Jos A van der Hage, J Sven D Mieog, Cornelis JH van de Velde, Hein Putter, Harry Bartelink, Marc J van de Vijver

miR-24-2 controls H2AFX expression regardless of gene copy number alteration and induces apoptosis by targeting antiapoptotic gene BCL-2: a potential for therapeutic intervention

Niloo Srivastava, Siddharth Manvati, Archita Srivastava, Ranjana Pal, Ponnusamy Kalaiarasan, Shilpi Chattopadhyay, Sailesh Gochhait, Raina Dua, Rameshwar NK Bamezai

ERBB receptors in cancer: signaling from the inside

Carlos L Arteaga

Impact of UGT2B7 His268Tyr polymorphism on the outcome of adjuvant epirubicin treatment in breast cancer

Sumit Parmar, Julia Stingl, Ariana Huber-Wechselberger, Alexander Kainz, Wilfried Renner, Uwe Langsenlehner, Peter Krippl, Jürgen Brockm？ller, Elisabeth Haschke-Becher

Analysis of tumor environmental response and oncogenic pathway activation identifies distinct basal and luminal features in HER2-related breast tumor subtypes

Michael L Gatza, Hsiu-Ni Kung, Kimberly L Blackwell, Mark W Dewhirst, Jeffrey R Marks, Jen-Tsan Chi

Stat3 and CCAAT/enhancer binding protein beta (C/EBP-beta) regulate Jab1/CSN5 expression in mammary carcinoma cells

Terry J Shackleford, Qingxiu Zhang, Ling Tian, Thuy T Vu, Anita L Korapati, Angela M Baumgartner, Xiao-Feng Le, Warren S Liao, Francois X Claret

Endocrine resistance in breast cancer: new roles for ErbB3 and ErbB4

Robert L Sutherland

From bone to breast and back - the bone cytokine RANKL and breast cancer

Lorenz C Hofbauer, Tilman D Rachner, Christine Hamann

Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study

Kristine H Allin, B？rge G Nordestgaard, Henrik Flyger, Stig E Bojesen

β1 integrin mediates an alternative survival pathway in breast cancer cells resistant to lapatinib

Catherine Huang, Catherine C Park, Susan G Hilsenbeck, Robin Ward, Mothaffar F Rimawi, Yen-chao Wang, Jiang Shou, Mina J Bissell, C Kent Osborne, Rachel Schiff

Telomerase expression and telomere length in breast cancer and their associations with adjuvant treatment and disease outcome

Lingeng Lu, Chong Zhang, Gongjian Zhu, Melinda Irwin, Harvey Risch, Guido Menato, Marco Mitidieri, Dionyssios Katsaros, Herbert Yu

Second malignancies in breast cancer patients following radiotherapy: a study in Florence, Italy

Wei Zhang, Aldo Becciolini, Annibale Biggeri, Paolo Pacini, Colin R Muirhead

Genetic variation in the genome-wide predicted estrogen response element-related sequences is associated with breast cancer development

Jyh-Cherng Yu, Chia-Ni Hsiung, Huan-Ming Hsu, Bo-Ying Bao, Shou-Tung Chen, Giu-Cheng Hsu, Wen-Cheng Chou, Ling-Yueh Hu, Shian-Ling Ding, Chun-Wen Cheng, Pei-Ei Wu, Chen-Yang Shen

Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis

Ola Blixt, Deanna Bueti, Brian Burford, Diane Allen, Sylvain Julien, Michael Hollingsworth, Alex Gammerman, Ian Fentiman, Joyce Taylor-Papadimitriou, Joy M Burchell

Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifen

Xianglin Wu, Malayannan Subramaniam, Sarah B Grygo, Zhifu Sun, Vivian Negron, Wilma L Lingle, Matthew P Goetz, James N Ingle, Thomas C Spelsberg, John R Hawse

©2008-2020 OALib, Inc | Public user content licensed CC-BY 4.0 unless otherwise specified. OALib ISSN Online: 2333-9721 OALib ISSN Print: 2333-9705